Product Information
CLOMIPRAMINE 50 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2257 per EA under NDC 59651038201. Its NADAC has been published 152 times since Aug 2, 2023.
Strength
50 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651038201
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLOMIPRAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216440On Market Since
3/20/2023
Pharmacological Classes
Price Statistics
The NADAC for CLOMIPRAMINE 50 MG CAPSULE has been published 152 times since Aug 2, 2023, and over the history we have for it it has declined 46.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2257 per EA |
|---|---|
| All-time high | $0.4242 (Jan 10, 2024) |
| All-time low | $0.2016 (May 22, 2024) |
| 52-week high | $0.2915 |
| 52-week low | $0.2257 |
| Median price | $0.2904 |
| Average price | $0.2974 |
| Largest weekly change | +43.5% (Jun 19, 2024) |
| Weeks tracked | 152 |
| Tracking since | Aug 2, 2023 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLOMIPRAMINE 50 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLOMIPRAMINE 50 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.2257 per EA (NDC 59651038201), effective Jun 24, 2026.
How has the price of CLOMIPRAMINE 50 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLOMIPRAMINE 50 MG CAPSULE has declined 46.7%. It has been tracked across 152 weekly CMS publications since Aug 2, 2023.
What are the highest and lowest recorded NADAC prices for CLOMIPRAMINE 50 MG CAPSULE?
Since Aug 2, 2023, the NADAC for CLOMIPRAMINE 50 MG CAPSULE has ranged from a low of $0.2016 (May 22, 2024) to a high of $0.4242 (Jan 10, 2024), with a median of $0.2904 per EA.
Are there cheaper alternatives to CLOMIPRAMINE 50 MG CAPSULE?
8 NADAC-published products share the same active ingredient, strength, and dosage form as CLOMIPRAMINE 50 MG CAPSULE, but none are currently priced below it.
Who manufactures CLOMIPRAMINE 50 MG CAPSULE?
CLOMIPRAMINE 50 MG CAPSULE (NDC 59651038201) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification